LifeSync Robotics Secures Seed Round from Pipal Principal, Achieves USD 10 Million Valuation

Singapore – 28th October, 2025 – Pipal Principal, a leading venture capital firm focused on deep tech innovations, has led a seed investment in Lifesync Technologies Pte Ltd (operating as LifeSync Robotics), a pioneering Singapore-based startup specializing in autonomous surgical robotics. This strategic round values LifeSync Robotics at a USD 10 million valuation and aims to accelerate the development and commercialization of advanced AI-driven surgical solutions for orthopedic and minimally invasive spine procedures.

Founded in 2024 in Singapore, LifeSync Robotics is transforming surgical practices through its flagship Asclepius robotic system. The platform boasts high-degree-of-freedom robotic arms, real-time 3D navigation, sub-millimeter precision, and advanced haptic feedback, empowering surgeons to perform complex procedures with greater accuracy, efficiency, and safety.

“This investment underscores our commitment to backing visionary companies in MedTech,” said Jacky Wong, Director at Pipal Principal. “LifeSync Robotics’ innovative approach to autonomous robotics addresses critical challenges in healthcare, and we are excited to support their mission to improve patient outcomes and democratize advanced surgical care.”

Fong Lau, Founder and CEO of LifeSync Robotics, added: “Partnering with Pipal Principal marks a pivotal milestone for us. Their expertise in high-threshold technologies like AI and biotechnology aligns perfectly with our goals. This investment will enable us to expand our R&D efforts and launch Asclepius to more markets, ultimately benefiting surgeons and patients worldwide.”

The new capital will fuel LifeSync Robotics’ growth, including team expansion, product refinement, and regulatory approvals. As part of the deal, Pipal Principal will provide strategic guidance as LifeSync Robotics go to market.

About Pipal Principal
Pipal Principal is a venture capital firm dedicated to investing in deep tech sectors, including artificial intelligence, biotechnology, and quantum computing. With a philosophy centered on fostering long-term innovation, Pipal Principal partners with entrepreneurs to build transformative technologies that drive global progress.

About Lifesync Technologies Pte Ltd
Lifesync Technologies Pte Ltd, branded as LifeSync Robotics, is a MedTech startup based in Singapore, focused on developing AI-powered autonomous surgical robots. Incubated at co11ab within the Lee Kong Chian School of Medicine’s Clinical Sciences Building, the company aims to enhance surgical effectiveness, safety, and increase accessibility to advanced procedures.

For media inquiries, please contact:
Pipal Principal Media Relations
Email: info@pipalprincipal.com
LifeSync Robotics Media Relations
Email: enquiry@lifesyncrobotics.com

Caption: LifeSync Robotics founders at Collab Novena. From left: Tim Chan (CFO), Fong Lau (CEO), and Wilson Fok (CTO)